Cartalax 20MG

Description

What is Cartalax?

Cartalax is the name used for the short peptide Ala-Glu-Asp (AED). It is discussed in experimental short-peptide research. Confirm the supplied sequence and batch identity before drawing comparisons with published studies.

Check the supplier specification and any available batch-specific analytical documentation for identity, composition and suitability for your laboratory method.

Published study findings and evidence limits

Cell-culture findings

Research on the AED tripeptide reported increased proliferation and changes in cellular-ageing markers in renal cell cultures. These are laboratory observations, not proof that Cartalax repairs cartilage, treats arthritis or slows human ageing.

Sources: AED tripeptide renal-cell study (2015).

Are benefits proven for this product? No clinical benefit has been established for the research material sold in this listing. Positive results for a characterised study formulation do not validate this batch, its safety or its suitability for human use. Research findings are provided for scientific context.

For research purposes only. Supplied exclusively for laboratory research and analytical use. Not for human or animal consumption, injection, therapeutic, diagnostic or cosmetic use. This product is not supplied as a medicine, food or dietary supplement. Information on this page describes research context and does not establish safety or efficacy for use in people or animals.